Sintered dicalcium pyrophosphate increases bone mass in ovariectomized rats

Jui Sheng Sun, Yi Chau Huang, Yang Hwei Tsuang, Li Ting Chen, Feng Huei Lin

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Bisphosphonates are synthetic pyrophosphate analogs that can be used for the treatment of osteoporosis. Sintered dicalcium pyrophosphate, as a pyrophosphate analog, may be useful in the clinical setting for osteoporosis. In this study, an ovariectomized rat model is used to evaluate the effects of orally administered sintered dicalcium pyrophosphate on bone mass. Thirty-six female rats were used in this study. They randomly were divided into six groups: a negative normal control group, a positive osteoporosis control group, and ovariectomized groups treated either with alendronate sodium (one group) or sintered dicalcium pyrophosphate (three groups, each at a different level). The animals were sacrificed at 4 weeks after treatment. For all the rats, whole blood samples were obtained for the biochemical study. Bone ashes of long bones were measured and studied and histologic studies of cancellous bone were carried out. The ingestion of either alendronate or sintered dicalcium pyrophosphate did not have any deleterious effect on the major visceral organs. Ingestion of alendronate or sintered pyrophosphate decreased the bony porosity and increased bone mineral contents in the long bones of ovariectomized rats. Thus sintered dicalcium pyrophosphate can increase bone mass in the ovariectomized rat.

Original languageEnglish
Pages (from-to)246-253
Number of pages8
JournalJournal of Biomedical Materials Research
Volume59
Issue number2
DOIs
Publication statusPublished - 2002
Externally publishedYes

Fingerprint

Rats
Bone
Alendronate
Ashes
diphosphoric acid
Diphosphonates
Animals
Blood
Minerals
Porosity
Sodium

Keywords

  • Alendronate
  • Bone mass
  • Osteoporosis
  • Ovariectomy
  • Sintered dicalcium pyrophosphate

ASJC Scopus subject areas

  • Biomedical Engineering
  • Biomaterials

Cite this

Sintered dicalcium pyrophosphate increases bone mass in ovariectomized rats. / Sun, Jui Sheng; Huang, Yi Chau; Tsuang, Yang Hwei; Chen, Li Ting; Lin, Feng Huei.

In: Journal of Biomedical Materials Research, Vol. 59, No. 2, 2002, p. 246-253.

Research output: Contribution to journalArticle

Sun, Jui Sheng ; Huang, Yi Chau ; Tsuang, Yang Hwei ; Chen, Li Ting ; Lin, Feng Huei. / Sintered dicalcium pyrophosphate increases bone mass in ovariectomized rats. In: Journal of Biomedical Materials Research. 2002 ; Vol. 59, No. 2. pp. 246-253.
@article{616aaccdcd6a48ed96dd9f894beebc5d,
title = "Sintered dicalcium pyrophosphate increases bone mass in ovariectomized rats",
abstract = "Bisphosphonates are synthetic pyrophosphate analogs that can be used for the treatment of osteoporosis. Sintered dicalcium pyrophosphate, as a pyrophosphate analog, may be useful in the clinical setting for osteoporosis. In this study, an ovariectomized rat model is used to evaluate the effects of orally administered sintered dicalcium pyrophosphate on bone mass. Thirty-six female rats were used in this study. They randomly were divided into six groups: a negative normal control group, a positive osteoporosis control group, and ovariectomized groups treated either with alendronate sodium (one group) or sintered dicalcium pyrophosphate (three groups, each at a different level). The animals were sacrificed at 4 weeks after treatment. For all the rats, whole blood samples were obtained for the biochemical study. Bone ashes of long bones were measured and studied and histologic studies of cancellous bone were carried out. The ingestion of either alendronate or sintered dicalcium pyrophosphate did not have any deleterious effect on the major visceral organs. Ingestion of alendronate or sintered pyrophosphate decreased the bony porosity and increased bone mineral contents in the long bones of ovariectomized rats. Thus sintered dicalcium pyrophosphate can increase bone mass in the ovariectomized rat.",
keywords = "Alendronate, Bone mass, Osteoporosis, Ovariectomy, Sintered dicalcium pyrophosphate",
author = "Sun, {Jui Sheng} and Huang, {Yi Chau} and Tsuang, {Yang Hwei} and Chen, {Li Ting} and Lin, {Feng Huei}",
year = "2002",
doi = "10.1002/jbm.1238",
language = "English",
volume = "59",
pages = "246--253",
journal = "Journal of Biomedical Materials Research - Part B Applied Biomaterials",
issn = "1552-4973",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Sintered dicalcium pyrophosphate increases bone mass in ovariectomized rats

AU - Sun, Jui Sheng

AU - Huang, Yi Chau

AU - Tsuang, Yang Hwei

AU - Chen, Li Ting

AU - Lin, Feng Huei

PY - 2002

Y1 - 2002

N2 - Bisphosphonates are synthetic pyrophosphate analogs that can be used for the treatment of osteoporosis. Sintered dicalcium pyrophosphate, as a pyrophosphate analog, may be useful in the clinical setting for osteoporosis. In this study, an ovariectomized rat model is used to evaluate the effects of orally administered sintered dicalcium pyrophosphate on bone mass. Thirty-six female rats were used in this study. They randomly were divided into six groups: a negative normal control group, a positive osteoporosis control group, and ovariectomized groups treated either with alendronate sodium (one group) or sintered dicalcium pyrophosphate (three groups, each at a different level). The animals were sacrificed at 4 weeks after treatment. For all the rats, whole blood samples were obtained for the biochemical study. Bone ashes of long bones were measured and studied and histologic studies of cancellous bone were carried out. The ingestion of either alendronate or sintered dicalcium pyrophosphate did not have any deleterious effect on the major visceral organs. Ingestion of alendronate or sintered pyrophosphate decreased the bony porosity and increased bone mineral contents in the long bones of ovariectomized rats. Thus sintered dicalcium pyrophosphate can increase bone mass in the ovariectomized rat.

AB - Bisphosphonates are synthetic pyrophosphate analogs that can be used for the treatment of osteoporosis. Sintered dicalcium pyrophosphate, as a pyrophosphate analog, may be useful in the clinical setting for osteoporosis. In this study, an ovariectomized rat model is used to evaluate the effects of orally administered sintered dicalcium pyrophosphate on bone mass. Thirty-six female rats were used in this study. They randomly were divided into six groups: a negative normal control group, a positive osteoporosis control group, and ovariectomized groups treated either with alendronate sodium (one group) or sintered dicalcium pyrophosphate (three groups, each at a different level). The animals were sacrificed at 4 weeks after treatment. For all the rats, whole blood samples were obtained for the biochemical study. Bone ashes of long bones were measured and studied and histologic studies of cancellous bone were carried out. The ingestion of either alendronate or sintered dicalcium pyrophosphate did not have any deleterious effect on the major visceral organs. Ingestion of alendronate or sintered pyrophosphate decreased the bony porosity and increased bone mineral contents in the long bones of ovariectomized rats. Thus sintered dicalcium pyrophosphate can increase bone mass in the ovariectomized rat.

KW - Alendronate

KW - Bone mass

KW - Osteoporosis

KW - Ovariectomy

KW - Sintered dicalcium pyrophosphate

UR - http://www.scopus.com/inward/record.url?scp=0036132639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036132639&partnerID=8YFLogxK

U2 - 10.1002/jbm.1238

DO - 10.1002/jbm.1238

M3 - Article

C2 - 11745559

AN - SCOPUS:0036132639

VL - 59

SP - 246

EP - 253

JO - Journal of Biomedical Materials Research - Part B Applied Biomaterials

JF - Journal of Biomedical Materials Research - Part B Applied Biomaterials

SN - 1552-4973

IS - 2

ER -